Achieves a key milestone as the school records an outstanding average score of 36.31 points, surpassing the global average ...
If approved, deucrictibant will be the first oral bradykinin B2 receptor antagonist to treat HAE attacksNDA includes positive data from successful clinical program demonstrating rapid relief and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results